December 12, 2017

BELLUS Health Closes $20M Common Share Financing

LAVAL, QC, Dec. 12, 2017 /CNW/ – BELLUS Health Inc. (TSX: BLU) (“BELLUS Health” or the “Company”), a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, today closed its previously announced equity offering, issuing a total of 52,631,580 common shares for gross proceeds of $20 million (the “Offering”). The majority of the Offering was subscribed to by healthcare specialized institutional investors and also included the participation by members of the senior management team and board of directors of the Company.

Read the full press release here.